Skip to main content
. 2016 Mar 11;23(1):6–12. doi: 10.1159/000443550

Table 4.

FI, BW and immunological parameters in experimental male (n = 6) and female (n = 6) rats before (pre-lesion) and after (post-lesion) PDA lesion

Parameters Experimental male
Experimental female
pre-lesion post-lesion pre-lesion post-lesion
FI, g/day 11.49±1.21 15.26±2.35*** 7.80±0.56 10.99±0.60††
BW, g 241.49±16.48 277.17±28.35* 162.28±9.85 174.13±11.21
CD4, pg/ml 58.36±4.75 68.34±5.36** 57.08±3.53 58.44±3.30
CD8, ng/ml 2.42±0.67 3.82±1.09* 1.46±1.20 1.26±0.50
Albumin, g/dl 3.25±0.10 3.12±0.23 3.43±0.15 3.22±0.33
Globulin, g/dl 3.55±0.21 3.13±0.16 3.78±0.15 3.37±0.77
A-G ratio 0.92±0.07 1.00±0.08 0.86±0.05 0.98±0.15
LW-BW ratio NA 0.03±0.003 NA 0.04±0.003
SW-BW ratio NA 0.0036±0.00055 NA 0.004±0.00056
Ig M, mg/ml NA 0.23±0.09 NA 0.21±0.07

Data expressed are mean ± SD.

* Represents comparison with pre-lesion experimental males; represents comparison with pre-lesion experimental females. The analysis of data was done by one-way ANOVA and post hoc by Tukey-Kramer test except for LW-BW ratio, SW-BW ratio and Ig M. Analysis of LW-BW ratio, SW-BW ratio and Ig M was done by Student's unpaired t test.

*

p < 0.05;

**

p < 0.01;

***

p < 0.001;

p < 0.05;

††

p < 0.01;

††† p < 0.001.

NA = Not applicable. Lesion means the lesion making needle electrode was introduced in to the PDA and current was passed.